Terug
Dagbereik
€ 15,82
€ 16,40
52-Weeksbereik
€ 10,45
€ 18,92
Volume
376.605
50D / 200D Gem.
€ 17,19
/
€ 15,41
Vorige Slotkoers
€ 15,72
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -15,6 | 0,4 |
| P/B | 0,9 | 2,9 |
| ROE % | -5,6 | 3,8 |
| Net Margin % | -7,1 | 3,9 |
| Rev Growth 5Y % | 7,9 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Hold
€ 18,90
+19.3%
Low: € 16,00
High: € 21,00
Forward K/W
20,5
Forward WPA
€ 0,77
WPA Groei (sch.)
+0,0%
Omzet Sch.
5,4 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 1,78
€ 1,76 – € 1,79
|
5,9 B | 1 |
| FY2028 |
€ 1,35
€ 1,04 – € 1,58
|
6,1 B | 3 |
| FY2027 |
€ 1,05
€ 0,94 – € 1,26
|
5,7 B | 8 |
Belangrijkste Punten
Revenue grew 7,89% annually over 5 years — modest growth
Negative free cash flow of -66,00M
Capital efficient — spends only 6,84% of revenue on capex
ROIC of 1,01% — low return on invested capital
Interest coverage of 0,37× — tight debt servicing
Groei
Revenue Growth (5Y)
7,89%
Revenue (1Y)6,47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-5,57%
ROIC1,01%
Net Margin-7,06%
Op. Margin3,12%
Veiligheid
Debt / Equity
0,83
Current Ratio1,55
Interest Coverage0,37
Waardering
P/E Ratio
-15,59
P/B Ratio0,87
EV/EBITDA66,66
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,47% | Revenue Growth (3Y) | 10,92% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7,89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5,10B | Net Income (TTM) | -360,00M |
| ROE | -5,57% | ROA | -2,57% |
| Gross Margin | 58,71% | Operating Margin | 3,12% |
| Net Margin | -7,06% | Free Cash Flow (TTM) | -66,00M |
| ROIC | 1,01% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,83 | Current Ratio | 1,55 |
| Interest Coverage | 0,37 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -15,59 | P/B Ratio | 0,87 |
| P/S Ratio | 1,10 | PEG Ratio | -1,26 |
| EV/EBITDA | 66,66 | Dividend Yield | 0,00% |
| Market Cap | 5,61B | Enterprise Value | 10,60B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,10B | 4,79B | 4,15B | 3,77B | 3,77B |
| Net Income | -360,00M | -317,00M | -260,00M | 6,00M | 182,00M |
| EPS (Diluted) | -1,02 | -0,90 | -0,74 | 0,04 | 0,52 |
| Gross Profit | 3,00B | 2,92B | 2,50B | 2,25B | 2,30B |
| Operating Income | 159,00M | 162,00M | 130,00M | 207,00M | 329,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 14,02B | 13,47B | 13,44B | 11,14B | 10,82B |
| Total Liabilities | 7,50B | 6,93B | 6,52B | 4,04B | 1,42B |
| Shareholders' Equity | 6,45B | 6,47B | 6,85B | 7,03B | 9,33B |
| Total Debt | 5,37B | 4,94B | 4,68B | 2,55B | 140,00M |
| Cash & Equivalents | 383,00M | 305,00M | 334,00M | 380,00M | 174,00M |
| Current Assets | 2,98B | 2,79B | 2,74B | 2,14B | 1,64B |
| Current Liabilities | 1,92B | 1,74B | 1,58B | 1,30B | 1,10B |